SARS-Cov-2 infection in asthma patients treated with biologics
A. Papaioannou (Athens, Greece), E. Fouka (Thessaloniki, Greece), ?. Tzanakis (Crete, Greece), K. ?ntoniou (Crete, Greece), ?. Samitas (Athens , Greece), ?. ?ervas (Athens , Greece), ?. ?ostikas (Ioannina, Greece), ?. Bartziokas (Ioannina, Greece), ?. Porpodis (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), ?. ?zouvelekis (Patras, Greece), I. Gerogianni (Larissa, Greece), ?. ?otsiou (Larissa, Greece), ?. ?akris (Athens, Greece), ?. ?ovina (Athens, Greece), G. Vlachou (Tripoli, Greece), ?. ?arkatos (Heraklion, Greece), S. Vittorakis (Chania, Greece), ?. ?atsoulis (Thessaloniki, Greece), I. Papanikolaou (Corfu, Greece), P. ?atsaounou (Athens, Greece), P. Steiropoulos (Alexandroupolis, Greece), D. Latsios (Drama, Greece), K. Dimakou (Athens, Greece), G. Hillas (Athens, Greece), S. ?ryfon (Thessaloniki, Greece), A. Georgopoulou (Thessaloniki, Greece), P. Avarlis (Kalamata, Greece), P. Bakakos (Athens, Greece), ?. ?arkopooulou (minapaspala@gmail.com, Greece), ?. Gaki (Trikala, Greece), A. Paspala (Thessaloniki , Greece), ?. Kyriakaki (Athens, Greece)
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Papaioannou (Athens, Greece), E. Fouka (Thessaloniki, Greece), ?. Tzanakis (Crete, Greece), K. ?ntoniou (Crete, Greece), ?. Samitas (Athens , Greece), ?. ?ervas (Athens , Greece), ?. ?ostikas (Ioannina, Greece), ?. Bartziokas (Ioannina, Greece), ?. Porpodis (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), ?. ?zouvelekis (Patras, Greece), I. Gerogianni (Larissa, Greece), ?. ?otsiou (Larissa, Greece), ?. ?akris (Athens, Greece), ?. ?ovina (Athens, Greece), G. Vlachou (Tripoli, Greece), ?. ?arkatos (Heraklion, Greece), S. Vittorakis (Chania, Greece), ?. ?atsoulis (Thessaloniki, Greece), I. Papanikolaou (Corfu, Greece), P. ?atsaounou (Athens, Greece), P. Steiropoulos (Alexandroupolis, Greece), D. Latsios (Drama, Greece), K. Dimakou (Athens, Greece), G. Hillas (Athens, Greece), S. ?ryfon (Thessaloniki, Greece), A. Georgopoulou (Thessaloniki, Greece), P. Avarlis (Kalamata, Greece), P. Bakakos (Athens, Greece), ?. ?arkopooulou (minapaspala@gmail.com, Greece), ?. Gaki (Trikala, Greece), A. Paspala (Thessaloniki , Greece), ?. Kyriakaki (Athens, Greece). SARS-Cov-2 infection in asthma patients treated with biologics. 4057
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: